Latest news with #LTFoodsLtd
Mint
29-05-2025
- Business
- Mint
Recommended stocks to buy today: Top stock picks by market experts for 29 May
The Nifty 50 slipped 63 points, or 0.3%, to close at 24,752, while the Sensex shed 240 points, or 0.29%, ending at 81,312. Sectoral weakness in FMCG, auto, pharma, and metal stocks further weighed on the index. Overall, the market remained cautious ahead of key upcoming events, including the release of GDP growth data and the monthly F&O expiry. Here are the top stock picks for today as recommended by some of India's top market experts. Top 3 stock recommendations for today, 29 May, by Ankush Bajaj Buy: Mazagon Dock Shipbuilders Ltd (Current price: ₹3,663) Buy: LT Foods Ltd (Current price: ₹422) Read more| NTPC's project execution delays remain its Achilles heel Two stock recommendations for today, 29 May, by MarketSmith India: Indraprastha Gas Ltd (current price: ₹213) Also Read: Four stocks to watch as India's space economy eyes $44 billion by 2033 SBFC Finance Ltd (current price: ₹108.50) Stocks to trade today as recommended by Trade Brains Portal: Balkrishna Industries Ltd (Current price: ₹ 2472) The company operates five tyre manufacturing plants across Rajasthan, Maharashtra, and Gujarat. In FY25, it sold 3,15,273 metric tonnes (MT) of tyres, marking 8% year-on-year growth. Financial performance (FY25): Revenue: ₹10,447 crore (+11.5% YoY) Ebitda: ₹2,682 crore (+16% YoY) Ebitda margin: 25.26% (+50 bps YoY) PAT: ₹1,655 crore (+12.5% YoY) Of total FY25 volumes, 59.9% came from agriculture and 36.6% from the off-the-road (OTR) segment. Europe accounted for 45.1% of volumes, while India contributed 28.6%. BKT has guided for 17% CAGR in revenue through FY30, aiming to reach ₹23,000 crore. It plans to invest ₹3,500 crore over the next three years to expand facilities in Bhuj for carbon black, power generation, CV tyres, rubber tracks, and PCR tyres. In the OHT segment, ongoing capex and de-bottlenecking will boost capacity by 35,000 MTPA to 425,000 MTPA. The company aims to raise the OHT segment's contribution to 70% of total revenue by FY30. Read more | Tata Sons feels the heat as TCS shrinks dividend for the first time in 20 years Symphony Ltd (Current price: ₹ 1214) The company has built strong IP-led differentiation, holding 201 trademarks, 64 registered designs, 15 copyrights, and 48 patents. Its product range includes 15+ industrial and commercial cooler models, backed by direct presence on four continents. Financial performance (FY25): Revenue: ₹1,576 crore (+36% YoY) EBITDA: ₹316 crore (+83% YoY) PAT: ₹213 crore (+44% YoY) Of total revenue, 90% ( ₹1,065 crore) came from the domestic market, with the remaining 10% ( ₹117 crore) from exports. Symphony pegs its global brand value at ₹13,000 crore. The company is focusing on expanding exports, particularly to the USA, Brazil, Europe, the Middle East, and other high-potential regions. Brazil, the world's fourth-largest cooler market, remains a strategic focus. Symphony plans to deepen its product offerings and expand its dealer network. It is also investing in innovation—offering features like digital controls, fuzzy logic, stylized design, and low-resource optimization. Having pioneered BLDC (brushless DC motor) coolers in India, Symphony is now exploring the BLDC fan market. It aims to tap into the growing $2 billion segment, expected to expand at 9–9.5% CAGR through 2029. Two stocks as recommended by Raja Venkatraman of NeoTrader Astra Microwave Products has delivered a solid financial performance in Q4FY25, showcasing strong growth in the aerospace and defence sector. The last reported numbers indicated that the revenue has now moved to ₹407.85 crore, reflecting a 15.23% year-over-year increase. Astra Microwave maintained an operating margin of 26.60%, demonstrating profitability despite market competition. On a quarter-on-quarter basis, revenue spiked by 57.75%, increasing from ₹258.54 crore in Q3 FY25 to ₹407.85 crore in Q4. Similarly, net income rose 54.94% QoQ, reinforcing financial strength. Another interesting newsflow is that Radhakishan Damani, a well-known investor, has returned to the company, participating in this fundraise, which further highlights the growing appeal of Astra Microwave's market prospects. In addition to financial instruments, Astra Microwave has undergone leadership and board changes, introduced new strategic perspectives while adjusting to evolving industry dynamics. The stock after a sterling performance till May 2024 faced a huge selloff much ahead of the market exhaustion and the profit booking that ensued resulted had undergone a painful scenario in the last set of weeks indicating that the time is challenging. However, the strong decline had erased 50% of the rise seen since March 2023 to some strong set of supports around 600. Around this level, the prices encountered some steady buying interest that held back the decline, push the prices higher. The strong and steady rise that we witnessed backed by buoyant financials and robust participation helped the prices surge higher. Eventually the rise managed to create a fresh new high and the robust participation is indicating a buying opportunity at current and on declines. Currently the strong surge seen in the prices has resulted in the prices doubling from the March lows highlighting the strong recovery seen in this counter. The quick turnaround in the trend of Astra Microwave's share price, signaling strong investor confidence and optimism about future prospects. As we look into the future, Astra Microwave's focus on financial discipline, operational efficiency, and strategic investments will play a crucial role in shaping its future growth trajectory and establishing itself as a leading player in the defence industry. With increasing revenue, profitability improvements, investor confidence, and corporate initiatives, Astra Microwave is positioned for sustained expansion. Considering the current scenario, one should consider buying at current levels and on dips near ₹1070 with a stop below ₹1045 for a rise to ₹1280-1325. GSK, is a global healthcare company specializing in pharmaceuticals, vaccines, and consumer healthcare products. It is one of the world's largest research-based pharmaceutical companies, focused on discovering, developing, manufacturing, and marketing human health products. GlaxoSmithKline has a long history, with its origins in India dating back to 1924. In the last reported numbers of Q4 FY25 GlaxoSmithKline Pharmaceuticals Ltd. (GSK) has demonstrated strong financial performance in, reinforcing its position in the pharmaceutical sector. The company reported a 35% increase in net profit, reaching ₹263 crore, compared to ₹194.48 crore in the same quarter last year. Revenue from operations rose to ₹974.37 crore, reflecting steady growth. GSK's full-year revenue stood at ₹3,723 crore, marking a 9% increase, while profit after tax before exceptional items surged 32% to ₹915 crore. The company also announced a final dividend of ₹42 per equity share, highlighting its commitment to shareholder returns. After a volatile upward trajectory since October 2023 the ride lower from July 2024 was a scary one as the fast-paced decline had no respite and combined with the bearish market forces the trends capitulated. However, since the beginning of 2025 the situation began to improve and the prices also factored the volatility surrounding the Trump Tariff showdown. As things began to clear regarding his stance on Pharma and the implementation of the tariff the resistances began to give away. As seen on the higher timeframe charts , Glaxo demonstrated long body candles highlighting the robust participation. With the momentum too favouring some potential upside the tailwinds in this counter could carry the prices higher. The prices have been witnessing rampant volatility and the swift recovery is definitely a signature of more upside in store. Looking ahead, GSK remains committed to sustained above-market growth, with a focus on innovation and strategic expansion. The company's 100th Annual General Meeting is scheduled for June 27, 2025, where further strategic decisions are expected. With strong financial results, new product launches, and positive investor sentiment, GSK is well-positioned for continued success in the pharmaceutical industry. With robust volumes building up one can consider buying dips near ₹3180, stop ₹3100 target ₹3480-3650. Also Read: LIC's growth perils curb stock's valuation Ankush Bajaj is a Sebi-registered research analyst. His registration number is INH000010441. Raja Venkatraman is co-founder, NeoTrader. His Sebi-registered research analyst registration no. is INH000016223. MarketSmith India: Trade name: William O'Neil India Pvt. Ltd; Sebi-registered research analyst registration number: INH000015543 Trade Brains Portal is a stock analysis platform. Its trade name is Dailyraven Technologies Pvt. Ltd, and its Sebi-registered research analyst registration number is INH000015729. Investments in securities are subject to market risks. Read all the related documents carefully before investing. Registration granted by Sebi and certification from NISM in no way guarantees performance of the intermediary or provide any assurance of returns to investors. Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before making any investment decisions.
Time of India
15-05-2025
- Business
- Time of India
LT Foods Q4 profit up 7% to Rs 161 crore, FY25 revenue crosses $1 billion mark
New Delhi: FMCG firm LT Foods Ltd on Thursday reported 6.83 per cent increase in consolidated net profit at Rs 160.51 crore for March quarter FY25, led by rise in margins and distribution expansion. It had reported a net profit of Rs 150.24 crore for the January-March period a year ago, according to a regulatory filing from LT Foods Ltd, which owns basmati rice brands Daawat and Royal. Revenue from operations was at Rs 2,228.36 crore in March quarter as against Rs 2,074.81 crore a year ago. Total expenses were at Rs 2,048.91 crore, up 7.9 per cent year-on-year. Total income, which includes other revenue, was at Rs 2,259.63 crore, up 8.02 per cent from the year-ago period. In FY25, LT Foods' net profit was up 2.37 per cent to Rs 611.80 crore, from Rs 597.59 crore a year ago. Total income rose to Rs 8,769.93 crore in the quarter, crossing the billion-dollar milestone. Its basmati and other speciality rice business in FY25 grew 10 per cent on a YoY basis on account of increased investment in brand and marketing, said LT Foods in its earnings statement. The Organic Food and Ingredients business recorded a 29 per cent growth, and its international business delivered a strong performance, with all key markets contributing to growth. Commenting on results, Managing Director & CEO Ashwani Arora said:"FY25 has been a landmark year for LT Foods, as we crossed the USD 1 billion revenue milestone-a strong reflection of our resilient business model, portfolio of food brands and deep consumer commitment. "Our resilient business model, focus on quality, and understanding of evolving consumer needs have helped us deliver a strong 12 per cent year-on-year revenue growth," he said. The board of LT Foods in a meeting held on Thursday recommended a final dividend of Re 1 per equity share of face value of Re 1 each for financial year 2024-25. Shares of LT Foods Ltd on Thursday settled at Rs 363.15 apiece on BSE, down 1.55 per cent from the previous close.
Economic Times
15-05-2025
- Business
- Economic Times
LT Foods Q4 Results: Profit up 7% to Rs 161 crore, FY25 revenue crosses $1 billion mark
FMCG firm LT Foods Ltd on Thursday reported 6.83 per cent increase in consolidated net profit at Rs 160.51 crore for March quarter FY25, led by rise in margins and distribution expansion. It had reported a net profit of Rs 150.24 crore for the January-March period a year ago, according to a regulatory filing from LT Foods Ltd, which owns basmati rice brands Daawat and Royal. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads FMCG firm LT Foods Ltd on Thursday reported 6.83 per cent increase in consolidated net profit at Rs 160.51 crore for March quarter FY25, led by rise in margins and distribution expansion. It had reported a net profit of Rs 150.24 crore for the January-March period a year ago, according to a regulatory filing from LT Foods Ltd, which owns basmati rice brands Daawat and from operations was at Rs 2,228.36 crore in March quarter as against Rs 2,074.81 crore a year expenses were at Rs 2,048.91 crore, up 7.9 per cent year-on-year. Total income, which includes other revenue, was at Rs 2,259.63 crore, up 8.02 per cent from the year-ago FY25, LT Foods' net profit was up 2.37 per cent to Rs 611.80 crore, from Rs 597.59 crore a year ago. Total income rose to Rs 8,769.93 crore in the quarter, crossing the billion-dollar basmati and other speciality rice business in FY25 grew 10 per cent on a YoY basis on account of increased investment in brand and marketing, said LT Foods in its earnings Organic Food and Ingredients business recorded a 29 per cent growth, and its international business delivered a strong performance, with all key markets contributing to on results, Managing Director & CEO Ashwani Arora said:"FY25 has been a landmark year for LT Foods, as we crossed the USD 1 billion revenue milestone-a strong reflection of our resilient business model, portfolio of food brands and deep consumer commitment."Our resilient business model, focus on quality, and understanding of evolving consumer needs have helped us deliver a strong 12 per cent year-on-year revenue growth," he board of LT Foods in a meeting held on Thursday recommended a final dividend of Re 1 per equity share of face value of Re 1 each for financial year 2024-25. Shares of LT Foods Ltd on Thursday settled at Rs 363.15 apiece on BSE, down 1.55 per cent from the previous close.
Time of India
15-05-2025
- Business
- Time of India
LT Foods Q4 Results: Profit up 7% to Rs 161 crore, FY25 revenue crosses $1 billion mark
FMCG firm LT Foods Ltd on Thursday reported 6.83 per cent increase in consolidated net profit at Rs 160.51 crore for March quarter FY25, led by rise in margins and distribution expansion. It had reported a net profit of Rs 150.24 crore for the January-March period a year ago, according to a regulatory filing from LT Foods Ltd, which owns basmati rice brands Daawat and Royal. Revenue from operations was at Rs 2,228.36 crore in March quarter as against Rs 2,074.81 crore a year ago. Total expenses were at Rs 2,048.91 crore, up 7.9 per cent year-on-year. Total income, which includes other revenue, was at Rs 2,259.63 crore, up 8.02 per cent from the year-ago period. In FY25, LT Foods' net profit was up 2.37 per cent to Rs 611.80 crore, from Rs 597.59 crore a year ago. Total income rose to Rs 8,769.93 crore in the quarter, crossing the billion-dollar milestone. Its basmati and other speciality rice business in FY25 grew 10 per cent on a YoY basis on account of increased investment in brand and marketing, said LT Foods in its earnings statement. Live Events The Organic Food and Ingredients business recorded a 29 per cent growth, and its international business delivered a strong performance, with all key markets contributing to growth. Commenting on results, Managing Director & CEO Ashwani Arora said:"FY25 has been a landmark year for LT Foods, as we crossed the USD 1 billion revenue milestone-a strong reflection of our resilient business model, portfolio of food brands and deep consumer commitment. "Our resilient business model, focus on quality, and understanding of evolving consumer needs have helped us deliver a strong 12 per cent year-on-year revenue growth," he said. The board of LT Foods in a meeting held on Thursday recommended a final dividend of Re 1 per equity share of face value of Re 1 each for financial year 2024-25. Shares of LT Foods Ltd on Thursday settled at Rs 363.15 apiece on BSE, down 1.55 per cent from the previous close.
